Pharma News
-
US-Taiwan partnership to advance manufacturing of Sjögren's Syndrome drug
Pharma | News | 0 Comment | 03 Dec, 2024
Ainos, Inc., an innovative healthcare company focused on advanced artificial intelligence (AI)-driven point-of-care test...Read more
-
Pharma | News | 0 Comment | 30 Nov, 2024
The University of Hong Kong (HKU), represented by Versitech Limited, has signed an agreement with China Merchants Group ...Read more
-
2025 Trends Buoying Boom Phase in APAC
Pharma | Analysis | By Ayesha Siddiqui | 0 Comment | 01 Dec, 2024
Antibody Drug Conjugates (ADCs) in Stoplight ADCs, touted as ‘magic bullets’ for targeted cancer ther...Read more
-
Pharma | News | 0 Comment | 27 Nov, 2024
A leading healthcare distribution company, Kingworld Medicines Group Limited, has officially started operations at the K...Read more
-
Zai Lab and Pfizer announce strategic collaboration for novel anti-bacterial drug XACDURO
Pharma | News | 0 Comment | 25 Nov, 2024
China-based Zai Lab and American pharmaceutical firm Pfizer have announced a strategic collaboration for the novel anti-...Read more
-
Pharma | News | 0 Comment | 24 Nov, 2024
Roche Pharmaceuticals has shared encouraging 16-week interim data from its ongoing phase 3b/4 SALWEEN trial, showing sig...Read more
-
Pharma | News | 0 Comment | 23 Nov, 2024
US-based Kura Oncology, Inc. and Japanese pharmaceutical firm Kyowa Kirin have entered into a global strategic collabora...Read more
-
South Korea approves Everest Medicines' NEFECON for treatment of Primary IgA Nephropathy
Pharma | News | 0 Comment | 23 Nov, 2024
China-based Everest Medicines has announced that NEFECON has received full approval from the Ministry of Food and Drug...Read more
-
Korea announces first-of-its-kind research agreement to discover radiopharmaceutical compounds
Pharma | News | 0 Comment | 19 Nov, 2024
SK Biopharmaceuticals, a biotech company in South Korea, has entered into an agreement with the Korea Institute of Radio...Read more
-
Lilly expands R&D footprint in Singapore with S$42 M investment in new Digital Health Innovation Hub
Pharma | News | 0 Comment | 14 Nov, 2024
Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lill...Read more
-
analytica Vietnam Expands for 2025 with Addition of New Hall
Pharma | News | 0 Comment | 12 Nov, 2024
• The largest edition yet, nearly double the size of the 2023 edition.• Hall A1 fully booked six months in adv...Read more
-
Singapore launches new robotics and advanced pharma manufacturing degrees
Pharma | News | 0 Comment | 11 Nov, 2024
Nanyang Technological University, Singapore (NTU Singapore) is introducing two new undergraduate degree programmes in ro...Read more
-
Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Another Round of Tariffs or Stumble?
Pharma | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 09 Nov, 2024
With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...Read more
-
AstraZeneca breaks ground new Antibody Drug Conjugate (ADC) Manufacturing Facility in Singapore
Pharma | News | By Hithaishi C Bhaskar | 0 Comment | 07 Nov, 2024
AstraZeneca held a groundbreaking ceremony at their Singapore ADC Manufacturing Facility on 7 November to commemorate th...Read more
-
Inocras and Summit Pharma International Corp collaborate to transform clinical genomics in Japan
Pharma | News | 0 Comment | 06 Nov, 2024
US-based Inocras Inc. and Summit Pharmaceuticals International Corporation have signed a Memorandum of understanding (Mo...Read more
-
Pharma | News | 0 Comment | 05 Nov, 2024
Eisai Co. and Eisai’s corporate venture capital subsidiary, Eisai Innovation, Inc. have announced that Eisai Innov...Read more
-
Japan's Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market
Pharma | News | 0 Comment | 04 Nov, 2024
Japan-headquartered Shimadzu Corporation has announced its investment in US-based Sepragen Corporation, a leading compan...Read more
-
Taiwan's Formosa Pharmaceuticals marks first entry into EU market for ophthalmic therapies
Pharma | News | 2 Comment | 31 Oct, 2024
Taiwan-based Formosa Pharmaceuticals has entered into an exclusive licensing agreement with DÁVI Farmacêuti...Read more
